Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

Conditions studied: Solid and Hematological Malignancies

In brief

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-363, KITE-753, KITE-197, and anitocabtagene autoleucel in participants of Kite-sponsored interventional studies.

Key facts

Study ID

NCT05041309

Run by

Kite, A Gilead Company

People needed

1000

Starts

2021-12-15

Expected to finish

2040-12-01

Last updated by the study team

2026-05-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The individual must have received an infusion of gene-modified cells in a completed Kite-sponsored parent study, has not withdrawn full consent, and has discontinued or completed the post-treatment follow-up period in the parent study, as applicable
• The individual must understand and voluntarily sign an Informed Consent Form (ICF) or an Informed Assent Form prior to any study-related assessments or procedures being conducted
• In the investigator's judgment, the individual is willing and able to complete the protocol-required follow-up schedule and comply with the study requirements for participation
• Exclusion Criteria: none

Where it is running

• City of Hope — Duarte, California, United States
• UC San Diego Moores Cancer Center — La Jolla, California, United States
• Children's Hospital Los Angeles — Los Angeles, California, United States
• University of California Los Angeles — Los Angeles, California, United States
• Children's Hospital of Orange County — Orange, California, United States
• Stanford University — Palo Alto, California, United States
• University of California Davis Comprehensive Cancer Center — Sacramento, California, United States
• University of California, San Francisco Medical Center — San Francisco, California, United States
• Colorado Blood Cancer Institute — Denver, Colorado, United States
• Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• Sylvester Comprehensive Cancer Centre — Miami, Florida, United States
• Moffitt Cancer Center — Tampa, Florida, United States
• Ann& Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• University of Chicago Medical Center Clinical Laboratories — Chicago, Illinois, United States
• Loyola University Medical Center — Maywood, Illinois, United States
• University of Iowa — Iowa City, Iowa, United States
• The University of Kansas Cancer Center Westwood — Westwood, Kansas, United States
• University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Karmanos Cancer Center Institute — Detroit, Michigan, United States
• Washington University — St Louis, Missouri, United States
• University of Nebraska — Omaha, Nebraska, United States
• John Theurer Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• Banner MD Anderson Cancer Center — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.